Advertisement FreeSlate Becomes Independent To Offer Integrated Workflow Solutions For R&D Organisations - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

FreeSlate Becomes Independent To Offer Integrated Workflow Solutions For R&D Organisations

FreeSlate, which previously operated as the high productivity research (HPR) business unit of Symyx Technologies, has announced its launch as an independent company focused on delivering integrated workflow solutions for R&D organizations seeking to maximize productivity and enhance innovation.

FreeSlate claimed that it provides researchers with increased experimental capacity and faster decision-making via its microscale, high-throughput technology, lab execution and analysis software, and experienced engineers and application scientists.

FreeSlate owns portfolio of IP covering high-throughput, parallel and microscale technology. The company’s offerings include integrated workflow systems and product-related services such as technology development, feasibility demonstration, proof of concept, and managed services.

John Senaldi, CEO of FreeSlate and former president of the HPR business unit at Symyx, said: “R&D organiations are continually seeking to accelerate discovery and development while avoiding unnecessary expenses.

“At FreeSlate, we use our expertise to deploy proven high-throughput technology solutions, enabling step-change gains in productivity and innovation for these customers. Now as an independent company, we can maintain an even sharper focus on ensuring such results within the R&D labs of our broad, global customer base.”